STOCK TITAN

Kimberly-Clark gets consent to remove Kenvue covenants

The consented indenture changes take effect only upon settlement, and the exchange offers are conditioned on completion of Kimberly-Clark’s acquisition of Kenvue.

(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
8-K

Rhea-AI Filing Summary

Kimberly-Clark Corporation reported that holders had tendered Kenvue notes for exchange into up to $7,000,000,000 aggregate principal amount of new Kimberly-Clark notes and cash, and that the required consents had been received for all outstanding series. Kenvue executed a supplemental indenture; the amendments eliminate substantially all restrictive covenants, certain events of default other than failure to pay principal, premium, or interest, the SEC reporting covenant, and certain restrictions on mergers and transfers of property or assets. The amendments become operative only upon settlement.

For each $1,000 principal amount validly tendered and not withdrawn by October 9, 2026, and accepted, eligible holders may receive $970 principal amount of new notes, a $30 principal amount early participation premium, and $1.00 cash. Later tenders through expiration qualify for the notes and premium, but not the cash payment. As of October 9, 2026, $1,475,569,000 of the $1,500,000,000 principal amount of 2053 notes had been tendered, or 98.37%. The stated expiration is October 27, 2026, unless extended; it is expected to be extended to on or about the pending acquisition’s closing. The offers are conditioned on completion of that acquisition, expected in the fourth quarter of 2026, and Kimberly-Clark does not anticipate settlement before November 2, 2026.

Filing Explained

Tendered Kenvue notes generally cannot be withdrawn except where law requires, and the related consents cannot be revoked, limiting holders’ ability to reverse participation; the exchange and indenture amendments still await settlement conditioned on the acquisition.

Item 8.01 Other Events Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Maximum aggregate principal amount of new notes Up to $7,000,000,000 New notes offered in exchange for Kenvue notes, plus cash
Exchange consideration per $1,000 principal amount $970 principal amount of Kimberly-Clark notes For notes tendered by October 9, 2026 and accepted
Early participation premium $30 principal amount of Kimberly-Clark notes per $1,000 principal amount tendered For notes tendered by October 9, 2026 and accepted
Cash payment $1.00 per $1,000 principal amount tendered For notes tendered by October 9, 2026 and accepted
Consideration for later tenders $970 principal amount of notes plus $30 principal amount premium per $1,000 principal amount tendered; no cash payment Tenders after October 9, 2026 and by the expiration date, if accepted
2053 notes tendered $1,475,569,000; 98.37% of $1,500,000,000 outstanding As of October 9, 2026
2028 notes tendered $736,389,000; 73.64% of $1,000,000,000 outstanding As of October 9, 2026
Early Participation Premium financial
"a $30 (the “Early Participation Premium”)"
supplemental indenture financial
"Kenvue has executed a supplemental indenture"
A supplemental indenture is a written amendment to the original bond agreement that changes specific terms of a debt contract, such as payment schedules, interest rates, collateral or covenant protections. Investors care because it alters the legal rights and risks tied to a security — like renegotiating a mortgage where the lender and borrower agree to new rules — and can affect a bond’s credit quality, yield and market value.
qualified institutional buyers regulatory
"reasonably believed to be “qualified institutional buyers”"
Qualified institutional buyers are large organizations, like big investment firms or banks, that are allowed to buy certain types of investment opportunities not available to everyday investors. Their size and experience matter because it ensures they understand and can handle complex financial deals, making markets more efficient and secure.
Expiration Date financial
"such date and time ... the “Expiration Date”"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does KMB offer for Kenvue notes tendered by the early participation date?

For each $1,000 principal amount validly tendered and not withdrawn by October 9, 2026, and accepted, eligible holders may receive $970 principal amount of Kimberly-Clark notes, a $30 principal amount early participation premium, and $1.00 in cash. Eligible holders must also beneficially own the notes at expiration to receive the premium and cash.

How many Kenvue 2053 notes were tendered in KMB’s exchange offer?

$1,475,569,000 principal amount of the 5.050% Senior Notes due 2053 was tendered as of October 9, 2026. That represented 98.37% of the series’ $1,500,000,000 principal amount outstanding.

When is KMB’s Kenvue note exchange expected to settle?

The offers are expected to expire on October 27, 2026, unless extended, and the expiration date is expected to be extended to on or about the closing of Kimberly-Clark’s pending acquisition of Kenvue. The acquisition is expected in the fourth quarter of 2026, and Kimberly-Clark does not anticipate settlement before November 2, 2026.

Who can participate in KMB’s Kenvue note exchange?

Eligible Holders include persons reasonably believed to be qualified institutional buyers under Rule 144A and qualifying non-U.S. persons under Regulation S, subject to stated regional restrictions. Eligible Holders must complete and return an Eligibility Letter to receive the exchange materials and participate.

Can holders withdraw Kenvue notes tendered in KMB’s exchange offer?

Tendered notes may not be withdrawn except in limited circumstances where additional withdrawal rights are required by law. Related consents may not be revoked and continue to be deemed delivered.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
false 0000055785 KIMBERLY CLARK CORP 0000055785 2026-10-09 2026-10-09 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION 

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): October 9, 2026

 

 

KIMBERLY-CLARK CORPORATION

(Exact name of registrant as specified in its charter)

 

Delaware 1-225 39-0394230
(State or other jurisdiction of
incorporation)
(Commission File Number) (I.R.S. Employer Identification
No.)

 

P.O. Box 619100

Dallas, Texas 75261-9100

(Address of Principal Executive Offices) (Zip Code)

 

(972) 281-1200

(Registrant’s telephone number, including area code)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class Trading Symbol(s) Name of each exchange on which
registered
Common Stock, $1.25 Par Value KMB The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

¨ Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

 

 

 

 

 

Item 8.01Other Events.

 

Exchange Offers and Consent Solicitations

 

On October 13, 2026, Kimberly-Clark Corporation, a Delaware corporation (“Kimberly-Clark”), announced the early tender results of its previously announced (i) offers to exchange (each, an “Exchange Offer” and, collectively, the “Exchange Offers”) any and all outstanding notes (the “Kenvue Notes”) issued by Kenvue Inc., a Delaware corporation (“Kenvue”), for up to $7.0 billion aggregate principal amount of new notes issued by Kimberly-Clark and cash and (ii) related solicitations of consents (each, a “Consent Solicitation” and, collectively, the “Consent Solicitations”) with respect to each series of Kenvue Notes to adopt certain proposed amendments (the “Amendments”) to the indenture (the “Kenvue Indenture”) governing the Kenvue Notes to (1) eliminate substantially all of the restrictive covenants in the Kenvue Indenture with respect to each series of Kenvue Notes, (2) eliminate certain of the events which may lead to an “Event of Default” in the Kenvue Indenture with respect to each series of Kenvue Notes (other than for the failure to pay principal, premium or interest), (3) eliminate the Securities and Exchange Commission reporting covenant in the Kenvue Indenture with respect to each series of Kenvue Notes and (4) eliminate certain restrictions on Kenvue in the Kenvue Indenture with respect to each series of Kenvue Notes from consolidating with or merging into any other person or conveying, transferring or leasing all or any of its properties and assets to any person.

  

Based on the early tenders as of 5:00 p.m., New York City time, on October 9, 2026 (the “Early Participation Date”), the requisite number of consents have been received to adopt the Amendments with respect to all outstanding series of Kenvue Notes. Kenvue has executed a supplemental indenture with respect to the Kenvue Indenture implementing the Amendments. The Amendments will become operative only upon settlement of the Exchange Offers. The settlement date for the Exchange Offers is expected to occur promptly after the Expiration Date (as defined below), which is expected to be extended to occur on or about the closing date of Kimberly-Clark’s previously announced pending acquisition of Kenvue (the “Acquisition”). Kimberly-Clark does not anticipate the settlement date to occur before November 2, 2026.

 

The Exchange Offers and Consent Solicitations are being made solely pursuant to the conditions set forth in the confidential offering memorandum and consent solicitation statement dated September 28, 2026 in a private offering exempt from, or not subject to, registration under the Securities Act of 1933, as amended. The Exchange Offers and Consent Solicitations will expire at 5:00 p.m., New York City time, on October 27, 2026, unless extended or terminated (such date and time with respect to an Exchange Offer, as may be extended, the “Expiration Date”), and are conditioned, among other things, upon the consummation of the Acquisition. The consummation of the Acquisition is expected to occur in the fourth quarter of calendar year 2026.

 

Kimberly-Clark also announced an amendment to the consideration available to eligible holders of Kenvue Notes who validly tender and do not validly withdraw their Kenvue Notes after the Early Participation Date and at or prior to the expiration date of the Exchange Offers. A copy of the press release issued by Kimberly-Clark is attached as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein in its entirety.

  

Item 9.01. Financial Statements and Exhibits.

 

(d) Exhibits.

 

Exhibit No. Description
99.1 Press Release issued by Kimberly-Clark Corporation on October 13, 2026.
104 The cover page from Kimberly-Clark Corporation’s Current Report on Form 8-K, formatted in Inline XBRL.

 

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  KIMBERLY-CLARK CORPORATION
   
Date: October 13, 2026 By: /s/ Nelson Urdaneta
  Name: Nelson Urdaneta
  Title: Senior Vice President and Chief Financial Officer

 

 

 

Exhibit 99.1

 

Kimberly-Clark Announces Successful Consent Solicitations for Kenvue Notes and Amendment to Terms of Exchange Offers

 

DALLAS, October 13, 2026 – Kimberly-Clark Corporation (NASDAQ: KMB) (“Kimberly-Clark”) announced today that the requisite number of consents have been received to adopt certain proposed amendments (the “Amendments”) with respect to all outstanding notes of Kenvue Inc. (NYSE: KVUE) (“Kenvue”). The results are based on (i) early tenders in the offers to exchange (each an “Exchange Offer” and, collectively, the “Exchange Offers”) any and all outstanding notes (the “Kenvue Notes”) issued by Kenvue for up to $7,000,000,000 aggregate principal amount of new notes to be issued by Kimberly-Clark (the “Kimberly-Clark Notes”) and cash and (ii) related consent solicitations (each, a “Consent Solicitation” and, collectively, the “Consent Solicitations”) being made by Kimberly-Clark on behalf of Kenvue to adopt the Amendments to the indenture (the “Kenvue Indenture”) governing the Kenvue Notes.

 

Kenvue has executed a supplemental indenture to the Kenvue Indenture that contains the Amendments. The Amendments will become operative only upon settlement of the Exchange Offers. The settlement date for the Exchange Offers (the “Settlement Date”) is expected to occur promptly after the Expiration Date (as defined below), which is expected to be extended to occur on or about the closing date of Kimberly-Clark’s previously announced pending acquisition of Kenvue (the “Acquisition”). Kimberly-Clark does not anticipate the Settlement Date to occur before November 2, 2026.

 

As of 5:00 p.m., New York City time, on October 9, 2026 (the “Early Participation Date”), the principal amounts of Kenvue Notes set forth in the table below were validly tendered and not validly withdrawn (and consents thereby validly given and not validly revoked). For each $1,000 principal amount of Kenvue Notes validly tendered and not validly withdrawn at or prior to the Early Participation Date and accepted by Kimberly-Clark, Eligible Holders (as defined below) will be eligible to receive $970 principal amount of Kimberly-Clark Notes of the applicable series (the “Exchange Consideration”), an early participation premium, payable in principal amount of Kimberly-Clark Notes of $30 (the “Early Participation Premium”) and $1.00 in cash (the “Cash Payment”), subject to rounding as described herein. The total consideration consists of (a) the Exchange Consideration plus (b) the Early Participation Premium plus (c) the Cash Payment. To be eligible to receive the Early Participation Premium and the Cash Payment, Eligible Holders must also beneficially own such Kenvue Notes at the Expiration Date. The Early Participation Premium and the Cash Payment will be paid on the Settlement Date to the noteholder of record on the Expiration Date.

 

Kimberly-Clark also announced an amendment to the consideration available to Eligible Holders of Kenvue Notes who validly tender and do not validly withdraw their Kenvue Notes after the Early Participation Date (as defined below) and at or prior to the Expiration Date. For each $1,000 principal amount of Kenvue Notes validly tendered and not validly withdrawn after the Early Participation Date but at or prior to the Expiration Date and accepted by Kimberly-Clark, Eligible Holders will be now eligible to receive the Exchange Consideration and the Early Participation Premium (but not the Cash Payment), subject to rounding as described herein.

 

Tendered Kenvue Notes may not be withdrawn, except in the limited circumstances where additional withdrawal rights are required by law. In addition, the related consents may not be revoked and such consents will continue to be deemed delivered.

 

1

 

  

Title of Series of Kenvue Notes   CUSIP/ISIN No. of
Kenvue Notes(1)
  Principal Amount
Outstanding
    Principal Amount
Tendered
as of the Early
Participation Date
    Percentage of
Outstanding
Principal Amount
Tendered
 
5.050% Senior Notes due 2028   49177JAF9 / US49177JAF93   $ 1,000,000,000     $ 736,389,000       73.64 %
5.000% Senior Notes due 2030   49177JAH5 / US49177JAH59   $ 1,000,000,000     $ 822,161,000       82.22 %
4.850% Senior Notes due 2032   49177JAS1 / US49177JAS15   $ 750,000,000     $ 700,312,000       93.37 %
4.900% Senior Notes due 2033   49177JAK8 / US49177JAK88   $ 1,250,000,000     $ 1,125,944,000       90.08 %
5.100% Senior Notes due 2043   49177JAM4 / US49177JAM45   $ 750,000,000     $ 728,341,000       97.11 %
5.050% Senior Notes due 2053   49177JAP7 / US49177JAP75   $ 1,500,000,000     $ 1,475,569,000       98.37 %
5.200% Senior Notes due 2063   49177JAR3 / US49177JAR32   $ 750,000,000     $ 724,580,000       96.61 %

 

(1)No representation is made as to the correctness or accuracy of the CUSIP numbers listed in this press release or printed on the Kenvue Notes. Such CUSIP numbers are provided solely for the convenience of the holders of Kenvue Notes.

 

Each Exchange Offer will expire at 5:00 p.m., New York City time, on October 27, 2026, unless extended or terminated (such date and time with respect to an Exchange Offer, as may be extended, the “Expiration Date”). The Exchange Offers and Consent Solicitations are being made pursuant to the terms and subject to the conditions set forth in the confidential offering memorandum and consent solicitation statement dated September 28, 2026 (as amended by this press release), and are conditioned upon the consummation of the Acquisition, which condition may not be waived by Kimberly-Clark, and certain other conditions that may be waived by Kimberly-Clark. The completion of the Acquisition is expected to take place in the fourth quarter of 2026, subject to the satisfaction of certain customary closing conditions.

 

The Kimberly-Clark Notes will be issued in minimum denominations of $2,000 and integral multiples of $1,000 in excess thereof. Kimberly-Clark will not accept any tender that would result in the issuance of less than $2,000 principal amount of any series of Kimberly-Clark Notes. The aggregate principal amount of each series of Kimberly-Clark Notes issued to each participating holder for each series of Kenvue Notes validly tendered (and not validly withdrawn) and accepted by Kimberly-Clark will be rounded down, if necessary, to the nearest whole multiple of $1,000 in excess of $2,000. This rounded amount will be the principal amount of Kimberly-Clark Notes you will receive, and Kimberly-Clark will pay a cash amount equal to the difference between the principal amount of the Kimberly-Clark Notes to which you would otherwise be entitled and the principal amount of the Kimberly-Clark Notes actually issued, plus any accrued and unpaid interest on such principal amount not received as a result of rounding down from the last interest payment date and up to (but not including) the Settlement Date.

 

The Kimberly-Clark Notes have not been registered under the U.S. Securities Act of 1933, as amended (the “Securities Act”), or securities laws of any state or any other jurisdiction. Unless registered, the Kimberly-Clark Notes may not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act. The Exchange Offers and Consent Solicitations will only be made, and the Kimberly-Clark Notes are only being offered and will only be issued, (a) to persons reasonably believed to be “qualified institutional buyers” (as defined in Rule 144A under the Securities Act) in compliance with Rule 144A under the Securities Act and (b) outside the United States to non-U.S. persons in compliance with Regulation S under the Securities Act, and (if a resident in a member state of the European Economic Area) such person is not a “EEA retail investor” or (if a resident in the United Kingdom) such person is not a “UK retail investor” (as defined in the confidential offering memorandum and consent solicitation statement) or (if resident in Canada) it is a “non-U.S. Canadian qualified offeree” (such persons, “Eligible Holders”). Eligible Holders who are located or resident outside of the United States may be subject to other eligibility criteria. Only Eligible Holders who properly complete and return the eligibility letter (the “Eligibility Letter”), which is available from the Information Agent (as defined below), are authorized to receive and review the confidential offering memorandum and consent solicitation statement and to participate in the Exchange Offers and Consent Solicitations.

 

2

 

 

Holders who desire to obtain a copy of the Eligibility Letter should contact D.F. King & Co., Inc., the information and exchange agent for the Exchange Offers and Consent Solicitations (the “Information Agent”), at: (800) 967-7635 (banks and brokers) or (646) 602-4897 (all others), at www.dfking.com/kmb-kvue or by email at kmb-kvue@dfking.com. D.F. King & Co., Inc. will also provide copies of the confidential offering memorandum and consent solicitation statement to Eligible Holders.

 

The Exchange Offers and Consent Solicitations are being made only pursuant to the confidential offering memorandum and consent solicitation statement. The confidential offering memorandum and consent solicitation statement and other documents relating to the Exchange Offers and Consent Solicitations will be distributed only to Eligible Holders. The Exchange Offers are not being made to holders of Kenvue Notes in any jurisdiction in which the making or acceptance thereof would not be in compliance with the securities, blue sky or other laws of such jurisdiction. The Kimberly-Clark Notes have not been approved or disapproved by any regulatory authority, nor has any such authority passed upon the accuracy or adequacy of the confidential offering memorandum and consent solicitation statement.

 

None of Kimberly-Clark, Kimberly-Clark’s subsidiaries, its and their respective directors or officers, the dealer managers and solicitation agents, the exchange agent, the information agent, any trustee for the Kimberly-Clark Notes or the Kenvue Notes, their respective affiliates, or any other person is making any recommendation as to whether holders should tender their Kenvue Notes in the Exchange Offers or deliver consents to the Amendments.

 

This press release does not constitute an offer to sell or purchase, or a solicitation of an offer to sell or purchase, or the solicitation of tenders or consents with respect to, any security in any jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction.

 

The Kimberly-Clark Notes offered in the Exchange Offers have not been registered under the Securities Act or any state securities laws. Therefore, the Kimberly-Clark Notes may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the Securities Act and any applicable state securities laws.

 

About Kimberly-Clark

 

Kimberly-Clark (NASDAQ: KMB) and its trusted brands are an indispensable part of life for people in more than 175 countries and territories. Our portfolio of brands, including Huggies, Kleenex, Scott, Kotex, Cottonelle, Poise, Depend, Pull-Ups, Goodnites, Intimus, Plenitud, Sweety, Softex, Viva and WypAll, hold No. 1 or No. 2 share positions in approximately 70 countries. Our company’s purpose is to deliver Better Care for a Better World. We are committed to using sustainable practices designed to support a healthy planet, build strong communities, and enable our business to thrive for decades to come.

 

3

 

 

Forward Looking Statements

 

Certain statements contained in this press release, including the expected timing of completion of the Acquisition and the Exchange Offers, constitute “forward-looking statements” within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, as amended, and are qualified by the inherent risks and uncertainties surrounding future expectations generally. There can be no assurance that these future events will occur as anticipated or that our results will be as estimated. Actual results could differ materially from those currently anticipated due to a number of risks and uncertainties, many of which are beyond our control. Forward-looking statements are based upon the expectations and beliefs of the management of Kimberly-Clark as of the date they were made and speak only as of the date they were made. We undertake no obligation to publicly update any forward-looking statements. Some of these forward-looking statements can be identified by words like “anticipate,” “approximately,” “believe,” “continue,” “could,” “estimate,” “expect,” “forecast,” “intend,” “may,” “outlook,” “plan,” “possible,” “potential,” “predict,” “project,” “seek,” “should,” “target,” “will” or “would,” the negative of these words, other terms of similar meaning or the use of future dates.

 

The assumptions used as a basis for the forward-looking statements include many estimates. Many factors outside our control, including risks and uncertainties around the Acquisition, could affect the realization of these estimates. Additional information and factors concerning these risks, uncertainties and assumptions can be found in Kimberly-Clark’s filings with the U.S. Securities and Exchange Commission (“SEC”), including the risk factors discussed in Kimberly-Clark’s most recent Annual Report on Form 10-K, as updated by its Quarterly Reports on Form 10-Q and future filings with the SEC. Forward-looking statements included herein are made only as of the date hereof and Kimberly-Clark undertakes no obligation to update any forward-looking statements, or any other information in this press release, as a result of new information, future developments or otherwise, or to correct any inaccuracies or omissions in them which become apparent. All forward-looking statements in this press release are qualified in their entirety by this cautionary statement.

  

4

Filing Exhibits & Attachments

4 documents

Keep reading